Praxis Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 40
Employees
  • Latest Deal Type
  • Series C1
  • Latest Deal Amount
  • $110M
Latest Deal Amount
  • Investors
  • 14

Praxis General Information

Description

Developer of therapies intended for patients and families affected by complex and debilitating brain disorders. The company's therapy targets genes that control the imbalance in neuronal signaling that underlies CNS disorders, enabling patients to get treatment for psychiatric disorders, movement disorders and rare pediatric epilepsies.

Contact Information

Formerly Known As
EpiPM Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1 Broadway
  • 16th floor
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

Praxis Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Praxis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C1) 28-Jul-2020 $110M 00000 Completed Clinical Trials - Phase 2
4. Later Stage VC 000.00 00000 Completed Clinical Trials - Phase 2
3. Early Stage VC 27-Jun-2019 0000 000.00 00000 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 20-Mar-2018 $18.8M $21.9M 000.00 Completed Stealth
1. Early Stage VC (Series A) 07-Nov-2016 $3.08M $3.08M 00.00 Completed Stealth
To view Praxis’s complete valuation and funding history, request access »

Praxis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 0.000
Series B 00,000,000 00.000000 00.00 00 00 00 00 00.000
Series A 8,075,799 $0.000100 $0.08 $1 $1 1x $1 23.3%
To view Praxis’s complete cap table history, request access »

Praxis Executive Team (7)

Name Title Board Seat Contact Info
Stuart Chaffee Ph.D Chief Financial Officer & Chief Business Officer
Steven Petrou Co-Founder, Chief Scientific Officer & Board Member
Carlos Loya Ph.D Director of Corporate Development
David Goldstein Ph.D Scientific Co-Founder
Marcio Souza Chief Executive Officer & President
You’re viewing 5 of 7 executive team members. Get the full list »

Praxis Board Members (10)

Name Representing Role Since
Alfred Sandrock Jr. Praxis Board Member 000 0000
Ari Brettman MD Blackstone Life Sciences Board Member 000 0000
Gregory Norden Self Board Member 000 0000
Kiran Reddy MD Self Co-Founder & Board Member 000 0000
Nicholas Galakatos Ph.D Blackstone Life Sciences Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Praxis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Praxis Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adage Capital Management Hedge Fund Minority 000 0000 000000 0
Ample Plus Fund Venture Capital Minority 000 0000 000000 0
Citadel (Hedge Fund) Hedge Fund Minority 000 0000 000000 0
Cormorant Asset Management Hedge Fund Minority 000 0000 000000 0
Eventide Asset Management Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »